Literature DB >> 9585872

Methods for sputum induction and analysis of induced sputum: a method for assessing airway inflammation in asthma.

J C Kips1, J V Fahy, F E Hargreave, P W Ind, J C in't Veen.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9585872

Source DB:  PubMed          Journal:  Eur Respir J Suppl        ISSN： 0904-1850


× No keyword cloud information.
  11 in total

Review 1.  The use of sputum cell counts to evaluate asthma medications.

Authors:  K Parameswaran; F E Hargreave
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

2.  Flow cytometry of sputum: assessing inflammation and immune response elements in the bronchial airways.

Authors:  John C Lay; David B Peden; Neil E Alexis
Journal:  Inhal Toxicol       Date:  2011-06       Impact factor: 2.724

3.  Soluble triggering receptor expressed on myeloid cells in sputum of patients with community-acquired pneumonia or pulmonary tuberculosis: a pilot study.

Authors:  G R Tintinger; J J van der Merwe; H Fickl; P Rheeder; C Feldman; R Anderson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-11       Impact factor: 3.267

Review 4.  Asthma outcomes: biomarkers.

Authors:  Stanley J Szefler; Sally Wenzel; Robert Brown; Serpil C Erzurum; John V Fahy; Robert G Hamilton; John F Hunt; Hirohito Kita; Andrew H Liu; Reynold A Panettieri; Robert P Schleimer; Michael Minnicozzi
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

Review 5.  Exhaled nitric oxide in the diagnosis and management of asthma: clinical implications.

Authors:  G W Rodway; J Choi; L A Hoffman; J M Sethi
Journal:  Chron Respir Dis       Date:  2009       Impact factor: 2.444

6.  Asthma control, quality of life and successful sputum induction.

Authors:  Sebastian Majewski; Piotr Cichocki; Małgorzata Stępnicka-Bindemann; Paweł Górski
Journal:  Arch Med Sci       Date:  2011-11-08       Impact factor: 3.318

7.  Patterns of inflammation and the use of reversibility testing in smokers with airway complaints.

Authors:  Niels H Chavannes; Juanita H J Vernooy; Tjard R J Schermer; Jan A Jacobs; Mieke A Dentener; Chris van Weel; Onno C P van Schayck; Emiel F M Wouters
Journal:  BMC Pulm Med       Date:  2006-06-01       Impact factor: 3.317

8.  Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis.

Authors:  Ioanna Tsiligianni; Katerina M Antoniou; Despina Kyriakou; Nikolaos Tzanakis; George Chrysofakis; Nikolaos M Siafakas; Demosthenes Bouros
Journal:  BMC Pulm Med       Date:  2005-06-24       Impact factor: 3.317

9.  Inflammatory and immunological profiles in patients with COPD: relationship with FEV 1 reversibility.

Authors:  Cleriston Farias Queiroz; Antonio Carlos Moreira Lemos; Maria de Lourdes Santana Bastos; Margarida Célia Lima Costa Neves; Aquiles Assunção Camelier; Natália Barbosa Carvalho; Edgar Marcelino de Carvalho
Journal:  J Bras Pneumol       Date:  2016 Jul-Aug       Impact factor: 2.624

10.  Evaluation of airway and circulating inflammatory biomarkers for cystic fibrosis drug development.

Authors:  Raksha Jain; Arthur Baines; Umer Khan; Brandie D Wagner; Scott D Sagel
Journal:  J Cyst Fibros       Date:  2020-07-01       Impact factor: 5.482
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.